Latvia

finalize the national multidrug and extensively drug-resistant TB (M/XDR-TB) response plan to ensure alignment with the post-2015 regional M/XDR-TB action plan;
ensure adequate monitoring and evaluation of progress achieved and gaps in TB and M/XDR-TB control (a monitoring and evaluation unit and plan have been developed);
provide technical assistance through monitoring missions;
distribute national TB and multidrug-resistant TB (MDR-TB) guidelines for TB specialists, Primary Health Care (PHC) doctors and other health-care providers, with provision of relevant training on the guidelines;
expand the End-TB Strategy through collaboration with PHC;
provide technical assistance to ensure that TB infection control is included in general infection control and the hygiene programme at country level, and that contact-tracing, contact investigations and active screening are expanded, particularly among vulnerable populations;
provide technical assistance to establish an algorithm for the rapid detection of MDR-TB using WHO-recommended rapid molecular techniques and enrolment of MDR-TB patients on treatment;
support continuing participation in clinical trials for new anti-TB drugs and new drugs for compassionate use;
support the WHO Collaborating Centre to share the country experience of MDR-TB management; and
support professional experts in Latvia to provide technical assistance to other countries